Heregulin / Neuregulin-1 (NRG1)

Class growth factor / ERBB-family ligandReceptor Receptor tyrosine kinase: ERBB3

Function

Heregulin, also known as neuregulin-1, is a peptide signaling hormone involved in nervous system communication, cardiac adaptation, cellular differentiation, myelin regulation, and tissue growth signaling. The hormone functions through ERBB receptor family pathways that regulate communication between neuronal tissues, cardiac muscle, epithelial environments, and connective tissue structures.

Heregulin contributes to Schwann cell signaling, synaptic organization, cardiac muscle adaptation, epithelial communication, and developmental tissue differentiation. The hormone also participates in regulation of cellular survival pathways, tissue repair mechanisms, and communication between nervous system and cardiovascular structures. Through these actions, it supports coordinated neural and cardiac physiological adaptation.

Production

Heregulin is produced by neurons, Schwann cells, endothelial cells, cardiac tissue, epithelial tissues, and additional endocrine-responsive organs. The hormone is synthesized as a transmembrane precursor protein that undergoes proteolytic cleavage to release the active extracellular signaling domain.

Production commonly increases during developmental growth, neural remodeling, tissue repair, and cardiovascular adaptation. Local synthesis allows targeted communication between neighboring cells involved in nervous system and tissue signaling pathways.

Regulation

Heregulin production is regulated by developmental signaling systems, neuronal activity, inflammatory cytokines, oxidative stress pathways, growth factor signaling, and tissue remodeling activity. Mechanical stress and injury-related pathways can influence expression within cardiac and neural tissues.

The hormone acts through ERBB receptor tyrosine kinase systems that activate MAP kinase signaling, phosphoinositide pathways, transcriptional regulation networks, and cellular survival signaling mechanisms. Receptor activation influences neural differentiation, cardiac communication, myelin maintenance, and epithelial growth pathways. Through these integrated growth-signaling systems, heregulin coordinates nervous system communication, cardiac adaptation, tissue differentiation, and regenerative cellular signaling.

Identity & Secretion

Primary Source GlandNeural tissues, epithelial tissues, tumor cells, stromal cells, endothelial cells
Secretion PatternParacrine and autocrine local signaling
Half-life3 min
PrecursorNRG1 proprotein

Nutrient Requirements

Nutrient Precursors
  • amino acids, protein synthesis substrates
Required Vitamins
  • vitamin-c,vitamin-b6,vitamin-b9,vitamin-a
Required Minerals
  • zinc,magnesium,selenium

Key Foods

  • broccoli,kale,spinach,garlic,yellow-onion,blueberry,pomegranate,green-tea-brewed,turmeric-ground,shiitake-raw

Targets & Signaling

Target Tissues
  • Lung, breast, pancreas, liver, ovary, nervous tissue, epithelial tissue, tumor microenvironment
Feedback Loops
  • Neuregulin signaling activates HER3/HER4 receptor complexes with feedback through AKT, ERK, STAT3, SRC, EGFR-family cross-talk, inflammatory cytokines, and survival signaling.
Second Messengers
  • PI3K,AKT,RAS,RAF,MEK,ERK,STAT3,SRC
Pathways Involved
  • pi3k-akt-pathway,mapk-erk-pathway,jak-stat-pathway,egfr-signaling,emt-signaling,angiogenesis-vegf-signaling,cell-cycle-control,nfkb-pathway

Key Functions

  • HER3/HER4 activation, epithelial growth signaling, survival signaling, migration signaling, angiogenesis support, neural communication, tissue repair.

Plant-Based Focus

  • Whole-food plant-based patterns rich in cruciferous vegetables, allium vegetables, berries, mushrooms, green tea, turmeric, legumes, and high-fiber foods provide phytochemicals studied for modulation of HER-family signaling, PI3K/AKT, MAPK/ERK, SRC, STAT3, oxidative stress, and inflammatory signaling.

Clinical Context

Normal RangeLocal tissue expression; not commonly measured as a routine circulating hormone
Unitscontext-dependent
Assay Notes
Neuregulin-1 is generally studied through tissue expression, RNA sequencing, tumor fusion analysis, immunohistochemistry, or pathway profiling rather than routine serum testing.

Linked Knowledge

Phytochemicals
  • quercetin,egcg,curcumin,sulforaphane,apigenin,luteolin,kaempferol,resveratrol,allicin
Amino Acids
  • glutamine,glycine,cysteine,arginine,serine
Foods
  • broccoli,kale,spinach,garlic,yellow-onion,blueberry,pomegranate,green-tea-brewed,turmeric-ground,shiitake-raw
Vitamins
  • vitamin-c,vitamin-b6,vitamin-b9,vitamin-a,vitamin-e
Minerals
  • zinc,magnesium,selenium,copper,manganese
Cancers (context)
  • Lung Cancer,Breast Cancer,Pancreatic Cancer,Ovarian Cancer,Liver Cancer,Gastric Cancer,Head and Neck Cancer,Bladder Cancer
Ailments
  • Chronic Inflammation,Oxidative Stress,Endothelial Dysfunction,Neural Fatigue,Slow Wound Healing

Dietary Modulators

  • Cruciferous vegetables, allium vegetables, berries, green tea, turmeric, mushrooms, legumes, whole grains, and high-fiber plant foods

Inhibitors / Activators

Inhibitors
  • quercetin,egcg,curcumin,sulforaphane,luteolin,apigenin,resveratrol
Activators
  • HER3 activation, HER4 signaling, inflammatory cytokines, epithelial injury, growth signaling, tumor microenvironment signaling

Summary

Neuregulin-1 is an ERBB-family ligand that activates HER3 and HER4 signaling. In cancer biology excessive NRG1 signaling can promote survival signaling, migration, proliferation, angiogenesis, and therapy resistance through PI3K/AKT and MAPK/ERK activation.

SUMMARY OF EFFECTS ON THE BODY

Neuregulin-1 supports tissue communication and repair under normal conditions, while dysregulated HER3/HER4 signaling is linked with abnormal proliferation, survival signaling, migration, angiogenesis, EMT-like behavior, and tumor progression.

Research

Neuregulin-1 is a major ERBB-family ligand involved in HER3/HER4 activation, epithelial signaling, neural communication, and tumor biology. NRG1 signaling activates PI3K/AKT, MAPK/ERK, SRC, and STAT3 pathways. NRG1 fusion events and HER3 activation are increasingly recognized in lung, pancreatic, breast, ovarian, and other epithelial cancers.
Created: May 9, 2026 Updated: May 27, 2026